$5.70 -0.09 (-1.55%)
2/10/2012 4:00 PM

GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Featured Broker Partners


Advertisement